Strategic Advisory Board
The Strategic Advisory Board (SAB) is composed of world-leading experts in stem cell and biomaterials technologies. CCRM shares its SAB with the Ontario Stem Cell Initiative (OSCI).
Co- Chairs
- Janet Rossant, Hospital for Sick Children Research Institute, Canada
- Peter Zandstra, Centre for Commercialization of Regenerative Medicine, Canada
Members
- George Daley, Children’s Hospital Harvard, USA
- Jeffrey Hubbell, École Polytechnique Fédérale de Lausanne, Switzerland
- Douglas Lauffenburger, Massachusetts Institute of Technology, USA
- Chris Mason, University College London, UK
- Shin-Ichi Nishikawa, Riken Centre for Developmental Biology, Japan
- Kathrin Plath, University of California, USA
- Michael Sefton, University of Toronto, Canada
- Fiona Watt, Cambridge Research Institute, UK
Honourary Member
- Shinya Yamanaka, Centre for iPS Cell Research and Application, Japan